Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls

Neurology. 1990 May;40(5):855-7. doi: 10.1212/wnl.40.5.855.

Abstract

We measured the concentration of C9 in the CSF and plasma of 93 consecutive patients referred for CSF examination in an outpatient multispecialty clinic. We noted no differences in CSF C9 or C9 index between patients with multiple sclerosis and neurologic controls.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Complement C9 / analysis
  • Complement C9 / cerebrospinal fluid*
  • Humans
  • Middle Aged
  • Multiple Sclerosis / blood
  • Multiple Sclerosis / cerebrospinal fluid*
  • Reference Values

Substances

  • Complement C9